Ruth L. Coleman
-
- Diabetes Treatment and Management 26
- Diabetes Management and Research 19
- Diabetes, Cardiovascular Risks, and Lipoproteins 13
-
- Cardiovascular Function and Risk Factors 14
- Nephrology top 5%
- Surgery top 10%
- Family Practice top 10%
-
- Health Systems, Economic Evaluations, Quality of Life 5
-
- Diet and metabolism studies 4
-
- Diabetes and associated disorders 4
-
- Metabolism, Diabetes, and Cancer 4
- Co-authors
- Rury R. HolmanRichard StevensAmanda AdlerHertzel C. GersteinTimothy M. E. DavisSophia ZoungasTimothy E. CravenMark Woodward
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Ruth L. Coleman
54 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 99
- Endocrinology, Diabetes and Metabolism 1.1k
- Cardiology and Cardiovascular Medicine 625
- Nephrology 136
- Surgery 392
- Family Practice 18
Countries citing papers authored by Ruth L. Coleman
This map shows the geographic impact of Ruth L. Coleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth L. Coleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth L. Coleman more than expected).
Fields of papers citing papers by Ruth L. Coleman
This network shows the impact of papers produced by Ruth L. Coleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth L. Coleman. The network helps show where Ruth L. Coleman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ruth L. Coleman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 1 | |
| 6 | 2021 | 75 | |
| 7 | 2021 | 35 | |
| 8 | 2020 | 11 | |
| 9 | 2020 | 12 | |
| 10 | 2020 | 49 | |
| 11 | 2020 | 39 | |
| 12 | 2019 | 31 | |
| 13 | Estimating cardiovascular risk and all-cause mortality in individuals with type 2 diabetes using the UKPDS Outcomes Model | 2019 | 1 |
| 14 | Are the cardiovascular risk reductions seen with empagliflozin in the EMPA-REG OUTCOME trial explained by conventional cardiovascular risk factors? | 2017 | 1 |
| 15 | An improved model to estimate lifetime health outcomes of patients with type 2 diabetes using 30-year follow-up data from the United Kingdom prospective diabetes study | 2011 | 1 |
| 16 | Performance of the UKPDS Risk Engine and the Framingham risk equations in estimating cardiovascular disease in the EPIC-Norfolk cohort | 2008 | 1 |
| 17 | Estimating cardiovascular disease risk for individuals with Type 2 diabetes: the new UKPDS Risk Engine | 2007 | 7 |
| 18 | Incident nephropathy in type 2 diabetes: a UKPDS Risk Equation | 2005 | 1 |
| 19 | A Cardiovascular Risk Calculator for Type 2 Diabetes | 2005 | 4 |
| 20 | Could non-HDL cholesterol replace total/HDL cholesterol ratio to estimate coronary heart disease risk in the UKPDS risk engine? | 2004 | 8 |
About Ruth L. Coleman
Ruth L. Coleman is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Nephrology, having authored 60 papers that have together received 1.9k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (26 papers), Diabetes Management and Research (19 papers), Cardiovascular Function and Risk Factors (14 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers), Diet and metabolism studies (4 papers), Diabetes and associated disorders (4 papers) and Metabolism, Diabetes, and Cancer (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.1k citations), Cardiology and Cardiovascular Medicine (625 citations) and Nephrology (136 citations). Ruth L. Coleman has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Rury R. Holman, Richard Stevens, Amanda Adler, Hertzel C. Gerstein, Timothy M. E. Davis, Sophia Zoungas, Timothy E. Craven, Mark Woodward, John Chalmers and Rodney A. Hayward. Their work appears in journals such as The Lancet, JAMA and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.